Folitrax 25 mg (Methotrexate) Chloroquine-resistant malaria reduce fluid retention

reduce fluid retention

but taking the medication after meals can minimize gastrointestinal side effects

dose adjustments and close monitoring are recommended under a physician’s guidance

apply a thin layer of Quadriderm RF to the affected area two to three times daily

Its broad-spectrum antibacterial activity makes it a preferred choice when targeting atypical pathogens and common bacterial agents

Folitrax 25 mg (Methotrexate) Chloroquine-resistant malaria reduce fluid retentionFolitrax 25mg contains Methotrexate, a medication utilized in the treatment of several conditions, including rheumatoid arthritis, psoriasis, and certain types of cancer.